Search Results 41-50 of 16791 for Azlocillin

  1. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

  2. A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination with Crizotinib - Mayo Clinic

    About this study. The purpose of the study is to evaluate safety and efficacy of AT13387 Alone and in Combination with Crizotinib in the Treatment of ...

  3. Study of Dexamethasone Plus IXAZOMIB or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis - Mayo Clinic

    Treatment options will include: dexamethasone alone, dexamethasone plus an alkylating agent (melphalan or cyclophosphamide), or dexamethasone plus an ...

  4. Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  5. Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Clinical trials - Oncology (Medical)

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

  7. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

    Liver damage can result from this potentially serious disease in which scarring blocks the bile ducts. A liver transplant is the only known cure.

  8. Odevixibat (oral route) - Side effects & dosage - Mayo Clinic

    Odevixibat is used to treat pruritus (skin itching) in patients with progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (ALGS). This ...

  9. A Study of ALX148 With Azacitidine for Higher Risk Myelodysplastic Syndrome - Mayo Clinic

    The purpose of this study is to evaluate ALX148 in combination with azacitidine for the treatment of patients with higher risk myelodysplastic syndrome (MDS).

  10. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

    Liver damage can result from this potentially serious disease in which scarring blocks the bile ducts. A liver transplant is the only known cure.